Catalyst Wire Dossier Catalyst Wire Dossier

Remsima SC

infliximab · Celltrion
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Remsima SC, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps

See pricing